| scholarly article | Q13442814 |
| P50 | author | David Molyneux | Q84598806 |
| P2093 | author name string | Lesong Conteh | |
| Thomas Engels | |||
| P2860 | cites work | The co-distribution of Plasmodium falciparum and hookworm among African schoolchildren | Q21034097 |
| Africa's 32 cents solution for HIV/AIDS | Q21092298 | ||
| Hookworm-related anaemia among pregnant women: a systematic review | Q21144550 | ||
| Stigma and the social burden of neglected tropical diseases | Q21562274 | ||
| The antipoverty vaccines | Q24290719 | ||
| Rescuing the bottom billion through control of neglected tropical diseases | Q24290723 | ||
| Disease and Development: Evidence from Hookworm Eradication in the American South | Q24607787 | ||
| Willingness to pay for prevention and treatment of lymphatic filariasis in Leogane, Haiti | Q24799349 | ||
| "Rapid-impact interventions": how a policy of integrated control for Africa's neglected tropical diseases could benefit the poor | Q24810845 | ||
| Defining the cost of the Egyptian lymphatic filariasis elimination programme | Q24814012 | ||
| Incorporating a rapid-impact package for neglected tropical diseases with programs for HIV/AIDS, tuberculosis, and malaria | Q25256957 | ||
| "Neglected" diseases but unrecognised successes--challenges and opportunities for infectious disease control | Q28273959 | ||
| National mass drug administration costs for lymphatic filariasis elimination | Q28469337 | ||
| Projected benefits from integrating NTD programs in sub-Saharan Africa | Q29398511 | ||
| Control of neglected tropical diseases | Q29547285 | ||
| Reassessment of the cost of chronic helmintic infection: a meta-analysis of disability-related outcomes in endemic schistosomiasis | Q29619819 | ||
| Evidence for an association between hookworm infection and cognitive function in Indonesian school children | Q30732146 | ||
| The real and the nominal? Making inflationary adjustments to cost and other economic data | Q33180473 | ||
| The future of onchocerciasis control in Africa | Q33305357 | ||
| Neglected patients with a neglected disease? A qualitative study of lymphatic filariasis | Q33308747 | ||
| Estimating the burden of rhodesiense sleeping sickness during an outbreak in Serere, eastern Uganda | Q33325763 | ||
| "It is me who endures but my family that suffers": social isolation as a consequence of the household cost burden of Buruli ulcer free of charge hospital treatment | Q33377060 | ||
| The costs of preventing and treating chagas disease in Colombia | Q33385135 | ||
| Deworming and development: asking the right questions, asking the questions right. | Q33403193 | ||
| Cost effectiveness in low- and middle-income countries: a review of the debates surrounding decision rules | Q33606843 | ||
| The impact of HIV and AIDS on Africa's economic development | Q33808858 | ||
| Cost effectiveness analysis of strategies to combat malaria in developing countries. | Q34165448 | ||
| The economic burden of malaria. | Q34292910 | ||
| Equity and health sector reforms: can low-income countries escape the medical poverty trap? | Q34374642 | ||
| Advancement of global health: key messages from the Disease Control Priorities Project | Q34514169 | ||
| The achievements and challenges of the African Programme for Onchocerciasis Control (APOC). | Q34703214 | ||
| Economic effects of echinococcosis | Q35073492 | ||
| Economic evaluation of Mectizan distribution | Q35743781 | ||
| Public-private partnerships in blindness prevention: reaching beyond the eye. | Q36320399 | ||
| A cost function for HIV prevention services: is there a 'u' - shape? | Q36391606 | ||
| The control of schistosomiasis and soil-transmitted helminths in East Africa | Q36483448 | ||
| Control of onchocerciasis | Q36492733 | ||
| Reconsidering the underestimated burden caused by neglected tropical diseases | Q36517740 | ||
| Effect of intermittent preventive treatment of malaria on health and education in schoolchildren: a cluster-randomised, double-blind, placebo-controlled trial. | Q36808782 | ||
| Cost and cost-effectiveness of nationwide school-based helminth control in Uganda: intra-country variation and effects of scaling-up | Q37087378 | ||
| The unacknowledged impact of chronic schistosomiasis | Q37102843 | ||
| Economic burden of dengue infections in India | Q37134806 | ||
| Leishmaniasis and poverty | Q38871144 | ||
| Priority setting and the 'neglected' tropical diseases | Q38930937 | ||
| Economic impact of dengue fever/dengue hemorrhagic fever in Thailand at the family and population levels. | Q38947937 | ||
| Combating the "other diseases" of MDG 6: changing the paradigm to achieve equity and poverty reduction? | Q39261696 | ||
| Multiple parasite infections and their relationship to self-reported morbidity in a community of rural Côte d'Ivoire | Q39385062 | ||
| Malaria control needs mass distribution of insecticidal bednets | Q39516130 | ||
| Are vaccination sites in Bangladesh scale efficient? | Q39545821 | ||
| Cost containment in a school deworming programme targeting over 2.7 million children in Vietnam | Q41669402 | ||
| Coverage and costs of a school deworming programme in 2007 targeting all primary schools in Lao PDR. | Q41681589 | ||
| Financial costs of deworming children in all primary schools in Cambodia | Q42275590 | ||
| Stigma: the stealth weapon of the NTD. | Q43151011 | ||
| Intestinal helminth infections, anaemia and labour productivity of female tea pluckers in Bangladesh | Q43651376 | ||
| Neglected tropical diseases and the Global Fund | Q43768498 | ||
| The African Programme for Onchocerciasis Control (APOC). | Q43932032 | ||
| Successful integration of insecticide-treated bed net distribution with mass drug administration in Central Nigeria. | Q44170296 | ||
| Global burden of trachoma and economics of the disease | Q44704130 | ||
| Healthcare seeking behaviour for Buruli ulcer in Benin: a model to capture therapy choice of patients and healthy community members | Q46160678 | ||
| Improving the health of the global poor | Q46351733 | ||
| HIV/AIDS, schistosomiasis, and girls | Q46426246 | ||
| APOC's strategy of community-directed treatment with ivermectin (CDTI) and its potential for providing additional health services to the poorest populations. African Programme for Onchocerciasis Control | Q46796253 | ||
| Household catastrophic health expenditure: a multicountry analysis | Q47754989 | ||
| Fighting tropical diseases | Q48025698 | ||
| Household strategies to cope with the economic costs of illness | Q48785330 | ||
| Economic effects of echinococcosis in a disease-endemic region of the Tibetan Plateau. | Q50765007 | ||
| Schistosomiasis control: experiences and lessons from China. | Q51676769 | ||
| Performance of predictors: evaluating sustainability in community-directed treatment projects of the African programme for onchocerciasis control. | Q52678157 | ||
| Worms: Identifying Impacts on Education and Health in the Presence of Treatment Externalities | Q56032192 | ||
| The Lancet's chronic diseases series | Q56420308 | ||
| Prevalence of urinary schistosomiasis and HIV in females living in a rural community of Zimbabwe: does age matter? | Q58380016 | ||
| Assessing the macroeconomic impact of a healthcare problem: The application of computable general equilibrium analysis to antimicrobial resistance | Q59210715 | ||
| Achieving the Millennium Development Goals | Q81552293 | ||
| P433 | issue | 9710 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | neglected tropical disease | Q929451 |
| socioeconomics | Q1643441 | ||
| P304 | page(s) | 239-47 | |
| P577 | publication date | 2010-01-16 | |
| P1433 | published in | The Lancet | Q939416 |
| P1476 | title | Socioeconomic aspects of neglected tropical diseases | |
| P478 | volume | 375 |
| Q55103665 | "Rapid impact" 10 years after: The first "decade" (2006-2016) of integrated neglected tropical disease control. |
| Q30395360 | A research agenda for helminth diseases of humans: Health research and capacity building in disease-endemic countries for helminthiases control |
| Q21144498 | A research agenda for helminth diseases of humans: The problem of helminthiases |
| Q21562257 | A research agenda for helminth diseases of humans: Towards control and elimination |
| Q26853165 | A research agenda for helminth diseases of humans: social ecology, environmental determinants, and health systems |
| Q33717067 | A systematic review of factors that shape implementation of mass drug administration for lymphatic filariasis in sub-Saharan Africa |
| Q92610556 | Advances in preclinical approaches to Chagas disease drug discovery |
| Q61800662 | Albendazole alone or in combination with microfilaricidal drugs for lymphatic filariasis |
| Q38383115 | Application of GIS technology in public health: successes and challenges. |
| Q92123754 | Are census data accurate for estimating coverage of a lymphatic filariasis MDA campaign? Results of a survey in Sierra Leone |
| Q56794453 | Chagas disease |
| Q36005931 | Chagas disease: assessing the existence of a threshold for bug infestation rate |
| Q59073293 | Challenges and recent progress in drug discovery for tropical diseases |
| Q37670897 | Challenges in the chemotherapy of Chagas disease: Looking for possibilities related to the differences and similarities between the parasite and host |
| Q33830703 | Challenges of health measurement in studies of health disparities |
| Q47230115 | Climate Change Contribution to the Emergence or Re-Emergence of Parasitic Diseases |
| Q54213787 | Climate Change and the Neglected Tropical Diseases. |
| Q35927181 | Concerted Efforts to Control or Eliminate Neglected Tropical Diseases: How Much Health Will Be Gained? |
| Q30393719 | Contributions of the Guinea worm disease eradication campaign toward achievement of the Millennium Development Goals |
| Q34331536 | Control of neglected tropical diseases needs a long-term commitment |
| Q26825338 | Cost and cost-effectiveness of soil-transmitted helminth treatment programmes: systematic review and research needs |
| Q35494378 | Costs of integrated mass drug administration for neglected tropical diseases in Haiti |
| Q66829246 | Current and promising novel drug candidates against visceral leishmaniasis |
| Q35805295 | De-politicizing parasites: reflections on attempts to control the control of neglected tropical diseases |
| Q38237274 | Development assistance for neglected tropical diseases: progress since 2009. |
| Q35748147 | Diagnosis of neglected tropical diseases among patients with persistent digestive disorders (diarrhoea and/or abdominal pain ≥14 days): Pierrea multi-country, prospective, non-experimental case-control study |
| Q39094061 | Disease burden of hepatitis E in a rural population in China: a community-based survey |
| Q39494603 | Disease control priorities for neglected tropical diseases: lessons from priority ranking based on the quality of evidence, cost effectiveness, severity of disease, catastrophic health expenditures, and loss of productivity |
| Q91941123 | Disease control through removal of population using Z-control approach |
| Q45794638 | Do Brazilian scientific journals promote the adherence of Chagas disease researchers to international ethical principles? |
| Q83185392 | Donors' commitments to neglected tropical diseases: not all bad |
| Q33892471 | Drug discovery and development for neglected diseases: the DNDi model |
| Q39712345 | Drugs for Neglected Diseases initiative model of drug development for neglected diseases: current status and future challenges |
| Q35192267 | Economic and disease burden of dengue in Mexico |
| Q47612597 | Economic evaluations of mass drug administration: The importance of economies of scale and scope |
| Q90234620 | Economic evaluations of onchocerciasis interventions: a systematic review and research needs |
| Q34297640 | Emerging and reemerging neglected tropical diseases: a review of key characteristics, risk factors, and the policy and innovation environment |
| Q93129634 | Epidemiological findings and policy implications from the nationwide schistosomiasis and intestinal helminthiasis survey in Sudan |
| Q55689918 | Equity and efficiency in the scaled-up implementation of integrated neglected tropical disease control: the health economics protocol of the COUNTDOWN multicountry observational study in Ghana, Cameroon and Liberia. |
| Q41987619 | Estimating the economic and social consequences for patients diagnosed with human African trypanosomiasis in Muchinga, Lusaka and Eastern Provinces of Zambia (2004-2014). |
| Q64056593 | Evaluation of emodepside in laboratory models of human intestinal nematode and schistosome infections |
| Q50786845 | Evaluation of synthetic peptides of WbSXP-1 for the diagnosis of human lymphatic filariasis |
| Q34019668 | Global burden, distribution, and interventions for infectious diseases of poverty |
| Q38894845 | Global trends in neglected tropical disease control and elimination: impact on child health |
| Q33984614 | Health education and the control of intestinal worm infections in China: a new vision |
| Q60932194 | Health, financial, and education gains of investing in preventive chemotherapy for schistosomiasis, soil-transmitted helminthiases, and lymphatic filariasis in Madagascar: A modeling study |
| Q46151124 | Impact of community-directed treatment on soil transmitted helminth infections in children aged 12 to 59 months in Mazabuka District, Zambia |
| Q26825064 | Impact of human schistosomiasis in sub-Saharan Africa |
| Q34184705 | Improving access to medicines for neglected tropical diseases in developing countries: lessons from three emerging economies. |
| Q51899077 | Incidence of kala-azar in Nepal: estimating the effects of individual and household characteristics. |
| Q35097828 | Incorporating scale dependence in disease burden estimates: the case of human African trypanosomiasis in Uganda |
| Q30378937 | Increasing European Support for Neglected Infectious Disease Research |
| Q55459515 | Innovation in neglected tropical disease drug discovery and development. |
| Q93163328 | Insecticidal and Genotoxic effects of some indigenous plant extracts in Culex quinquefasciatus Say Mosquitoes |
| Q39165581 | Interactions between 4-aminoquinoline and heme: Promising mechanism against Trypanosoma cruzi. |
| Q33603042 | Investment Success in Public Health: An Analysis of the Cost-Effectiveness and Cost-Benefit of the Global Programme to Eliminate Lymphatic Filariasis |
| Q110949012 | Kaempferol-3-O-α-(3,4-di-E-p-coumaroyl)-rhamnopyranoside from Nectandra oppositifolia releases Ca2+ from intracellular pools of Trypanosoma cruzi affecting the bioenergetics system |
| Q21134611 | Leishmaniasis worldwide and global estimates of its incidence |
| Q36531354 | Modelling the cost-effectiveness of mass screening and treatment for reducing Plasmodium falciparum malaria burden |
| Q35735934 | Neglected tropical diseases and the millennium development goals: why the "other diseases" matter: reality versus rhetoric |
| Q38223613 | Neglected tropical diseases: now more than just 'other diseases'--the post-2015 agenda |
| Q30061948 | Neglected tropical diseases: progress towards addressing the chronic pandemic |
| Q52648078 | Outcome of E1224-Benznidazole Combination Treatment for Infection with a Multidrug-Resistant Trypanosoma cruzi Strain in Mice. |
| Q28077177 | Parasitic diseases of the central nervous system: lessons for clinicians and policy makers |
| Q92184331 | People are neglected, not diseases: the relationship between disability and neglected tropical diseases |
| Q27004352 | Persistent digestive disorders in the tropics: causative infectious pathogens and reference diagnostic tests |
| Q36256196 | Prevalence of Schistosomes and Soil-Transmitted Helminths among Schoolchildren in Lake Victoria Basin, Tanzania |
| Q36256206 | Prevalence of Schistosomes and Soil-Transmitted Helminths and Morbidity Associated with Schistosomiasis among Adult Population in Lake Victoria Basin, Tanzania. |
| Q26864627 | Prevention and control of neglected tropical diseases: overview of randomized trials, systematic reviews and meta-analyses |
| Q26764931 | Productivity Loss Related to Neglected Tropical Diseases Eligible for Preventive Chemotherapy: A Systematic Literature Review |
| Q37554839 | Pterodon emarginatus oleoresin-based nanoemulsion as a promising tool for Culex quinquefasciatus (Diptera: Culicidae) control. |
| Q89037287 | Purinergic receptors and neglected tropical diseases: why ignore purinergic signaling in the search for new molecular targets? |
| Q33831770 | Quantifying quality of life and disability of patients with advanced schistosomiasis japonica |
| Q39415280 | Removing the neglect from neglected tropical diseases: the Rwandan experience 2008-2010. |
| Q55008133 | Screening a repurposing library, the Medicines for Malaria Venture Stasis Box, against Schistosoma mansoni. |
| Q39664921 | Search for a platelet-activating factor receptor in the Trypanosoma cruzi proteome: a potential target for Chagas disease chemotherapy |
| Q34331546 | Social sciences research in neglected tropical diseases 1: the ongoing neglect in the neglected tropical diseases |
| Q51740777 | Socioeconomic benefit to individuals of achieving 2020 targets for four neglected tropical diseases controlled/eliminated by innovative and intensified disease management: Human African trypanosomiasis, leprosy, visceral leishmaniasis, Chagas diseas |
| Q98166037 | Synthesis and antitrypanosomal activity of novel 1,4-dissubstituted-triazole compounds based on 2-nitroimidazole scaffold: a structure-activity relationship (SAR) study |
| Q28547416 | The Contributions of Onchocerciasis Control and Elimination Programs toward the Achievement of the Millennium Development Goals |
| Q30378480 | The Socioeconomic Benefit to Individuals of Achieving the 2020 Targets for Five Preventive Chemotherapy Neglected Tropical Diseases |
| Q30388508 | The contribution of mass drug administration to global health: past, present and future |
| Q43977651 | The cost of mapping trachoma: Data from the Global Trachoma Mapping Project |
| Q30061753 | The cross-cutting contribution of the end of neglected tropical diseases to the sustainable development goals |
| Q37278516 | The impact of an 8-year mass drug administration programme on prevalence, intensity and co-infections of soil-transmitted helminthiases in Burundi |
| Q47133891 | The monetary value of human lives lost due to neglected tropical diseases in Africa |
| Q36588778 | Towards an effective control programme of soil-transmitted helminth infections among Orang Asli in rural Malaysia. Part 1: prevalence and associated key factors |
| Q58109279 | TrypanocidalActivity of Natural Sesquiterpenoids Involves Mitochondrial Dysfunction, ROS Production and Autophagic Phenotype in Trypanosomacruzi |
| Q46582634 | Using the AD12-ICT rapid-format test to detect Wuchereria bancrofti circulating antigens in comparison to Og4C3-ELISA and nucleopore membrane filtration and microscopy techniques |
| Q36702409 | Yeast-based automated high-throughput screens to identify anti-parasitic lead compounds |
Search more.